KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P0
Near historical low
Average
8.06
Historical baseline
PeriodValueYoY Change
20250.00-
20240.00-
20230.00-
20220.00-
20210.00-100.0%
202014.14-27.6%
201919.53+237.8%
20185.78-78.0%
201726.24+76.4%
201614.88-